1. Community
  2. Bones, joints and muscles
  3. Lupus

Systemic Lupus Erythematosus - Possible breakthrough drug Lupuzor

Posted , 3 users are following.

Adele_J
Adele_J

Finally there could be hope for millions of sufferers of Systemic Lupus Erythematosus. Today UK company ImmuPharma announced the last patient had received their last dose in its Phase 3 trial of SLE drug Lupuzor (also known as IPP-201101 or Rigerimod) with the trial due to end in January 2018 and readout shortly afterwards. Results so far have been impressive, with the Phase 2b trial indicating Lupuzor could be more efficaceous, faster acting and lack the side effects of GSK's SLE drug Benlysta (Benlimumab) together with being available at a lower price. One to watch in the coming weeks.

3 likes, 1 reply

1 Reply

  • stella-z
    stella-z Adele_J

    Posted

    Thanks so much. Are there any updates on this great news?
Back to top

Report or request deletion

Thanks for your help!

We want the community to be a useful resource for our users but it is important to remember that the community are not moderated or reviewed by doctors and so you should not rely on opinions or advice given by other users in respect of any healthcare matters. Always speak to your doctor before acting and in cases of emergency seek appropriate medical assistance immediately. Use of the community is subject to our Terms of Use and Privacy Policy and steps will be taken to remove posts identified as being in breach of those terms.